CPT 0472U Early Sjögren’s ELISA Reimbursement | OpenPayer

Summary & Overview

CPT 0472U: Early Sjögren’s Syndrome ELISA Antibody Profile

CPT code 0472U designates a Proprietary Laboratory Analyses (PLA) test marketed by Immco Diagnostics Inc. for the Early Sjögren’s Syndrome Profile. The ELISA-based panel detects IgG, IgM, and IgA antibodies to CA VI, PSP, and SP1 in blood and reports semiqualitative positive/negative results that serve as predictive evidence of early Sjögren’s syndrome. Nationally, PLA codes like 0472U matter because they identify manufacturer-specific assays and affect how payers evaluate coverage, coding specificity, and claims adjudication for niche diagnostic tests.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise description of the test and its clinical context, an overview of typical sites of service and service type, and a summary of common billing modifiers and administrative details when available. The publication provides benchmarking context and policy-relevant notes for payers and provider billing teams, along with clinical background on the role of these antibody markers in identifying early-stage Sjögren’s syndrome. Data not available in the input is identified as such in relevant sections.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare0472UCPTProprietary Laboratory AnalysesEarly SjogrensELISASerologyLaboratory TestingAutoimmune Diagnostics

Billing Code Overview

CPT code 0472U is a Proprietary Laboratory Analyses (PLA) code that applies exclusively to the Early Sjögren’s Syndrome Profile developed by Immco Diagnostics Inc. The test uses enzyme–linked immunosorbent assay (ELISA) to measure immunoglobulin G (IgG), immunoglobulin M (IgM), and immunoglobulin A (IgA) antibodies directed against carbonic anhydrase VI (CA VI), parotid specific/secretory protein (PSP), and salivary protein (SP1). Results are reported semiqualitatively as positive or negative for the presence of these antibodies.

Service type: Laboratory testing using ELISA-based serologic antibody panel for early detection of Sjögren’s syndrome.

Typical site of service: Clinical laboratory processing a blood specimen; specimen collection may occur in outpatient clinics, physician offices, or phlebotomy centers.

Clinical & Coding Specifications

Clinical Context

A 42-year-old woman presents to a rheumatology clinic with a 9-month history of progressive dry mouth and dry eyes, intermittent parotid gland swelling, and new onset fatigue. The treating rheumatologist documents suspicion for early Sjögren’s syndrome based on symptoms and physical exam. A blood sample is collected in the clinic and sent to Immco Diagnostics Inc. for the Early Sjögren’s Syndrome Profile. The laboratory performs the proprietary enzyme–linked immunosorbent assay (ELISA) that measures IgG, IgM, and IgA antibodies to carbonic anhydrase VI (CA VI), parotid specific/secretory protein (PSP), and salivary protein (SP1). The test yields semiqualitative positive/negative results that the laboratory reports to the ordering provider as predictive evidence of early Sjögren’s syndrome. Typical workflow steps include: ordering the PLA test from the electronic health record, phlebotomy at the ambulatory clinic, specimen handling and shipment to the performing specialty lab, laboratory testing using the proprietary ELISA, and laboratory report review by the rheumatologist to guide further diagnostic evaluation such as ocular staining, salivary flow testing, or consideration of salivary gland biopsy.

Coding Specifications

Modifier	Description	When to Use
`00`	Default or unmodified service	Use when no special modifier applies; report the PLA code without additional modifier when service is routine.

CPT 0462U: Salivary Melatonin Profile (Circadian Phase Assessment)

CPT-0093U-COMPLYRX-LC-MSMS-URINE-MULTI-DRUG-SCREEN

CPT 0093U: ComplyRX™ LC–MS/MS Urine Multi-Drug Screen

CPT-0470U-HPV-SEQ-NGS-PLASMA-CTDNA-OROPHARYNGEAL-CANCER

CPT 0470U: HPV–SEQ NGS Plasma ctDNA Test for Oropharyngeal Cancer

CPT-0156U-SMASH-COPY-NUMBER-SEQUENCE-ANALYSIS-DEVELOPMENTAL-DISORDERS

CPT 0156U: SMASH™ Copy Number Sequence Analysis for Developmental Disorders

CPT-0349U-RIGHTMED-COMPREHENSIVE-PHARMACOGENOMIC-TEST

CPT 0349U: RightMed Comprehensive Pharmacogenomic NGS Test

CPT-0432U-KELHL11-ANTIBODY-TESTING-MAYO-CLINIC

CPT 0432U: Kelch–Like Protein 11 Antibody Test (Mayo Clinic)

CPT-0625U-TRUD-MDS-OSTEOPOROSIS-DNAMETHYLATION-TEST

CPT 0625U: TruD MDS Osteoporosis DNA Methylation Risk Test

CPT-0207U-DISCERN-SKIN-BASED-ERK1-ERK2-IMAGING-ALZHEIMERS

CPT 0207U: Discern™ Skin-Based ERK1/ERK2 Imaging for Alzheimer Disease

CPT-0317U-LUNGLB-FISH-BLOOD-ASSAY-LUNG-NODULE-STRATIFICATION

CPT 0317U: LungLB® FISH Blood Assay for Indeterminate Lung Nodules

CPT-0389U-KAWASAKI-RNA-EXPRESSION-RISK-SCORE

CPT 0389U: Kawasaki Disease RNA Expression Risk Score Test

Showing 1–10 of 536

Taxonomy Code	Specialty	Notes
207RH0000X	Rheumatology	Rheumatologists commonly order the Early Sjögren’s Syndrome Profile when evaluating suspected Sjögren’s syndrome.
2080P0206X	Clinical Pathology	Pathologists or clinical laboratory directors oversee testing quality and interpretation protocols for specialty labs performing PLA testing.
364S00000X	Laboratory Medicine	Laboratory medicine specialists direct performance and validation of proprietary ELISA assays in reference laboratories.
261QM0800X	Otolaryngology	Otolaryngologists (ENT) may be involved in management of salivary gland disorders and may order or interpret results in certain clinical pathways.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`M35.00`	Sicca syndrome, unspecified	Directly related to dry eyes and dry mouth symptoms evaluated with the Early Sjögren’s Syndrome Profile.
`M35.01`	Secondary Sjögren syndrome	Used when Sjögren’s features occur in the setting of another autoimmune disease such as rheumatoid arthritis.
`M35.02`	Primary Sjögren syndrome with organ involvement	Applied when serologic testing and clinical findings support primary Sjögren’s syndrome with systemic involvement.
`H04.123`	Dry eye syndrome, bilateral	Symptom code for keratoconjunctivitis sicca commonly evaluated alongside Sjögren’s testing.
`K11.7`	Disturbances of salivary secretion	Clinical code for xerostomia and salivary gland dysfunction that prompt ordering of the PLA test.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80101`	Therapeutic drug assay; immunoassay qualitative (e.g., drug of abuse)	Represents general immunoassay methodology; not specific to Sjögren’s PLA but conceptually related laboratory technique.
`80053`	Comprehensive metabolic panel; includes multiple chemistry tests	Often ordered concurrently to evaluate baseline organ function prior to autoimmune workup and to exclude metabolic causes of symptoms.
`83036`	Hemoglobin; glycosylated (A1c)	Frequently part of general laboratory evaluation in patients with systemic symptoms to assess for diabetes, which can contribute to sicca symptoms.
`86580`	Skin test and intermediate antigen test; e.g., miscellaneous	Represents ancillary immunologic testing codes sometimes used in immunology panels; used here as an example of related immunologic testing workflows.
`88305`	Surgical pathology, gross and microscopic examination	If salivary gland biopsy is performed following positive PLA results, this code represents pathology processing and interpretation.

OpenPayer